Test More of Your Knowledge of eNSCLC From ASCO 2024!
Do you remember the eNSCLC research presented at ASCO 2024? Test more of your knowledge with new questions and see how you rank!
Read More
Ad Code: Tecentriq - Display Banners Conference - CPE - Non-Priority Segment 3 - 102661
Test Your Knowledge of eNSCLC Presented at ASCO 2024!
Do you remember the eNSCLC research presented at ASCO 2024? Test your knowledge now and see how you rank!
Read More
ASCO 2024 eBook on eNSCLC
A curated eBook featuring ASCO 2024 eNSCLC-focused studies, findings, and expert opinions.
Read More
Why Do Physicians Order NSCLC Biomarker Tests, and Who Gets Appropriate Targeted Therapy?
Biomarker tests for non-small lung cancer (NSCLC) improve patient outcomes, but they are not available to everyone.
Read More
Molecular Testing Appears To Be Increasing in eNSCLC
An increasing number of patients with eNSCLC currently have access to biomarker testing and targeted therapies, according to the MYLUNG consortium.
Read More
AI’s Increasing Capacity to Outperform Human Detection of Lung Cancer
AI detects lung cancer better than humans do.
Read More
Ultrasensitive Circulating Tumor DNA Improves NSCLC Detection
Ultrasensitive Circulating Tumor DNA improves clinical sensitivity of minimal residual disease in early stage non-small cell lung cancer.
Read More
ASCO 2024: eNSCLC
The latest news from ASCO 2024 focused on eNSCLC including abstracts, features, and helpful conference information.
Read More
Survival Outcomes in Early-Stage NSCLC With Rare Mutations
The treatment landscape for non-small cell lung cancer has significantly evolved with the advent of targeted therapies.
Read More
Exploring Atezolizumab Combination Therapy for NSCLC: J-TAIL-2 Study
The following is a summary of “J-TAIL-2: A prospective observational study of atezolizumab (atezo)...
Read More
Examining Care Quality in Early-Stage Resected NSCLC: EGFR Testing and Adjuvant Therapy
The following is a summary of “Assessing quality of care in early-stage resected stage non-small...
Read More
Impact of Oncogenic Drivers and Immune Landscapes in YA with NSCLC
The following is a summary of “Young adults (YA) with non-small cell lung cancer (NSCLC): Snapshot...
Read More
ASCO Voices 2024
ASCO Voices has become an anticipated staple of the conference. It is an opportunity for physicians to share their platform and experiences on a scale unlike any other.
Read More
Places to Visit in Chicago
Are you traveling to Chicago for ASCO? Here’s some places to visit.
Read More
Which ASCO Ancillary Event Are You Excited to Attend?
What ASCO ancillary event are you excited to attend?
Read More
Industry Expert Theater
The Industry Expert Theater offers hour-long, nonaccredited educational presentations by industry leaders. These sessions will cover the latest advancements in oncology practices, products, services, and technologies.
Read More